AWE Board Member
Former CEO and President, Parsortix Inc.
Larissa Milne has over 25 years of commercial experience in the Life Sciences, developing and implementing growth
strategies for emerging and mid-size companies. Currently she acts as a Portfolio Management Consultant for Ben
Franklin Technology Partners (BFTP), advising life sciences companies in the BFTP portfolio on Board-related and
corporate issues. Most recently she was President and CEO of Parsortix, Inc., a start-up medical device company
developing microfluidic cell sorting technology for use with in-vitro diagnostics. Larissa created the overall
business strategy for Parsortix and managed the company through its formation, initial funding round and early
development. In 2005 she was interim CEO of Neuro Diagnostic Devices, where she secured seed funding and
facilitated the company’s sale from family owners to a venture capital group. From 2001 to 2004 Ms. Milne was with
BTG and managed a team in Diagnostics and Drug Delivery. While at BTG Larissa built and managed the company’s
Prenatal Diagnostic portfolio of intellectual property. Prior to BTG she held significant positions in sales,
marketing, business development and corporate strategy with Coulter Corporation (now Beckman Coulter), Bioject and
Fujirebio Diagnostics. Ms. Milne holds a BS in Biology from Muhlenberg College and an MBA from the LeBow College of
Business at Drexel University where she was a Beta Gamma Sigma Honors graduate.
Return to Leadership